Related Experiment Video
Updated: Jan 7, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Integration of epidemiological surveys, network pharmacology, and molecular docking simulation to explore the
Linhong Wang1,2, Zhongli Liao3, Guanhua Qiu1,2
1The Graduate School of Fujian Medical University, Fujian Medical University, Fuzhou, China.
Abstract:
Propofol is a widely used anesthetic that has been associated with post-anesthetic euphoria, particularly among women. Since anhedonia is a core component of female sexual dysfunction (FSD), we aimed to evaluate the clinical incidence of propofol-induced euphoria and explore its potential molecular mechanisms. A total of 300 patients undergoing gastrointestinal endoscopy with propofol anesthesia were assessed postoperatively using the Euphoria Rating Scale, Observer's Assessment of Alertness/Sedation Scale (OAA/S), and the Hospital Anxiety and Depression Scale (HADS). Network pharmacology and molecular docking were applied to identify relevant molecular targets and signaling pathways. Euphoria occurred in 28% (42/150) of female patients compared to 4.4% (6/135) of males (adjusted OR = 6.62; 95% CI, 2.46 to 17.81, p < 0.001). Network pharmacology revealed 37 intersecting targets between propofol and FSD. Functional enrichment highlighted estrogen-related signaling and cGMP-dependent pathways. Molecular docking confirmed strong binding affinities of propofol with ESR1, EGFR, APP, NR3C1, MDM2, and MAOB. Short-term exposure to propofol can induce euphoria more frequently in females and may positively modulate pathways linked to female sexual dysfunction. These findings suggest propofol may have potential therapeutic applications beyond anesthesia.
More Related Videos
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Quantitative Aspects of Drug-Receptor Interaction
Drug Discovery: Overview
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Parenteral Anesthetics: Overview

